title: Green pharmacy and pharmEcovigilance: prescribing and the planet.
abstract: Active pharmaceutical ingredients (APIs) are ubiquitous environmental contaminants, resulting primarily from excretion and bathing and from disposal of leftover drugs by consumers and healthcare facilities. Although prudent disposal of leftover drugs has attracted the most attention for reducing API levels in the aquatic environment, a more effective approach would prevent the generation of leftover drugs in the first place. Many aspects of the practice of medicine and pharmacy can be targeted for reducing environmental contamination by APIs. These same modifications--focused on treating humans and the environment as a single, integral patient--could also have collateral outcomes with improved therapeutic outcomes, and with a reduced incidence of unintended poisonings, drug interactions and drug diversion, and lower consumer costs.
authors: Office of Research and Development, US Environmental Protection Agency, Las Vegas, NV, USA. daughton.christian@epa.gov
authors: Christian G
authors: CG
authors: Daughton
authors: Ilene S
authors: IS
authors: Ruhoy
mesh_terms: D000818:Animals; D011307:Drug Prescriptions / Q000592:standards*; D004785:Environmental Pollutants / Q000009:adverse effects; D004787:Environmental Pollution / Q000517:prevention & control*; D055772:Green Chemistry Technology / Q000379:methods / Q000592:standards*; D006801:Humans; D060735:Pharmacovigilance; D010604:Pharmacy / Q000379:methods / Q000592:standards*
chemical_list: D004785:Environmental Pollutants